T2 Biosystems has initiated the direcT2 clinical trial of T2Candida, designed for the rapid and sensitive identification of five species of Candida. The direcT2 trial will provide data to support a regulatory submission for T2Candida. ...
Tags: T2 Biosystems, Clinical Trial
US-based T2 Biosystems has received a patent from US Patent and Trademark Office covering its T2Candida test. The patent describes the format and methodology of T2Candida test, desinged to detect and identify Candida species in a blood ...
Tags: T2 Biosystems, T2Candida test
The US Patent and Trademark Office (USPTO) has granted patent, number 8,409,807 to T2 Biosystems' patent application covering its T2Candida diagnostic test. The test identifies and detects sepsis-causing Candida species from whole blood ...
Tags: T2 Biosystems, T2candida Test, Patent
T2 Biosystems has announced data of its T2Hemostasis monitoring system at the 54th Annual Meeting of the American Society for Hematology (ASH) which is being held in Atlanta, Georgia, US. The system has the capability to characterize key ...
Tags: T2 Biosystems, monitoring system, key coagulation, platelet, health